Zynfuse
Zynfuse
As a leading innovator, Zynfuse Medical Technology Co., Ltd. leverages 12+ years of expertise to set benchmarks in the global orthopedic market. Our focus on elbow joint implants integrates advanced biomechanical design with high-strength biocompatible alloys, addressing the complex functional requirements of joint reconstruction.
The global demand for orthopedic implants is rising due to an aging demographic and increased surgical precision requirements. We facilitate global healthcare shifts through high-volume, high-compliance manufacturing.
We are currently pioneering AI-assisted surgical planning and 3D-printed patient-specific implants to improve long-term outcomes and patient recovery timelines.
With 68 dedicated inspection specialists, our ISO 13485-compliant workflows ensure that every product meets rigorous international standards, including FDA and CE benchmarks.
Established in 2016, we operate a 18,600 m² facility. We bridge the gap between complex surgical needs and industrial manufacturing reality.
Years Experience
R&D Engineers
New Products/Year
Annual Export
A: We utilize a multi-stage inspection process, including mechanical performance testing, biocompatibility verification, and fatigue analysis, overseen by 68 quality specialists.
A: Yes, we specialize in tailoring implant geometry and materials, leveraging our robust R&D team to provide fully customized medical solutions.
